WallStreetZenWallStreetZen

NASDAQ: CKPT
Checkpoint Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CKPT

Based on 1 analyst offering 12 month price targets for Checkpoint Therapeutics Inc

Min Forecast
$20.00+402.51%
Avg Forecast
$20.00+402.51%
Max Forecast
$20.00+402.51%

Should I buy or sell CKPT stock?

Based on 1 analyst offering ratings for Checkpoint Therapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CKPT's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CKPT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CKPT stock forecasts and price targets.

CKPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-04

1 of 1

Forecast return on equity

Is CKPT forecast to generate an efficient return?

Company
N/A
Industry
136.54%
Market
70.05%

Forecast return on assets

Is CKPT forecast to generate an efficient return on assets?

Company
N/A
Industry
22.45%

CKPT earnings per share forecast

What is CKPT's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.91
Avg 2 year Forecast
$0.14

CKPT revenue growth forecast

How is CKPT forecast to perform vs Biotechnology companies and vs the US market?

Company
317.32%
Industry
33.87%
Market
8.8%
CKPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CKPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CKPT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CKPT$3.98$20.00+402.51%Buy
CRBP$15.83$64.29+306.10%Strong Buy
TSVT$3.73$5.50+47.45%Hold
TRVI$2.49$9.14+267.19%Strong Buy
GNFT$3.83$13.00+239.43%Buy
View Top Biotech Stocks

Checkpoint Therapeutics Stock Forecast FAQ

Is Checkpoint Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CKPT) stock is to Buy CKPT stock.

Out of 1 analyst, 0 (0%) are recommending CKPT as a Strong Buy, 1 (100%) are recommending CKPT as a Buy, 0 (0%) are recommending CKPT as a Hold, 0 (0%) are recommending CKPT as a Sell, and 0 (0%) are recommending CKPT as a Strong Sell.

If you're new to stock investing, here's how to buy Checkpoint Therapeutics stock.

What is CKPT's earnings growth forecast for 2024-2025?

(NASDAQ: CKPT) Checkpoint Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.2%.

Checkpoint Therapeutics's earnings in 2024 is -$46,468,000.On average, 2 Wall Street analysts forecast CKPT's earnings for 2024 to be -$44,193,413, with the lowest CKPT earnings forecast at -$45,902,550, and the highest CKPT earnings forecast at -$42,484,275.

In 2025, CKPT is forecast to generate $6,836,550 in earnings, with the lowest earnings forecast at $6,836,550 and the highest earnings forecast at $6,836,550.

What is CKPT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CKPT) forecast ROE is N/A, which is considered weak.

What is CKPT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CKPT price target, the average CKPT price target is $20.00, with the highest CKPT stock price forecast at $20.00 and the lowest CKPT stock price forecast at $20.00.

The Wall Street analyst predicted that Checkpoint Therapeutics's share price could reach $20.00 by Dec 4, 2025. The average Checkpoint Therapeutics stock price prediction forecasts a potential upside of 402.51% from the current CKPT share price of $3.98.

What is CKPT's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: CKPT) Checkpoint Therapeutics's current Earnings Per Share (EPS) is -$1.84. On average, analysts forecast that CKPT's EPS will be -$0.91 for 2024, with the lowest EPS forecast at -$0.94, and the highest EPS forecast at -$0.87. In 2025, CKPT's EPS is forecast to hit $0.14 (min: $0.14, max: $0.14).

What is CKPT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CKPT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.45%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.